Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novogen Limited NVGN

Healthcare Drug Manufacturers - Specialty & Generic
"Novogen Ltd is a pharmaceutical drug development based on a simple benzopyran chemical structure. It is an emerging oncology-focused biotechnology company that develops anti-cancer drugs."

Recent & Breaking News (NDAQ:NVGN)

Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York

PR Newswire March 12, 2014

Novogen Selected to Present at Cavendish Global Health Impact Forum

PR Newswire March 10, 2014

Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing International Presence

PR Newswire March 4, 2014

Novogen to Host Corporate Update and Webcast

PR Newswire January 30, 2014

Novogen to Present at Biotech Showcase(TM) 2014

PR Newswire January 8, 2014

Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer

PR Newswire December 20, 2013

Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology

PR Newswire November 26, 2013

HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR

Accesswire November 25, 2013

Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer

PR Newswire November 6, 2013

SNTA, DNDN, ZGNX and NVGN added to NASDAQ Active Stock Watch List at EPR

Accesswire October 28, 2013

GPOR, LLTC, SVNT and NVGN added to NASDAQ Active Stock Watch List at GSR

Accesswire October 16, 2013

InvestorsGuru.com 40 Filtered Mid-Day Market Movers Recap

Investors Guru April 7, 2013

Free Research Reports on CHLN, MHR, MVIS and NVGN Issued by the Bedford Report

Marketwired April 5, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

Marketwired February 26, 2013

A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.

PR Newswire February 21, 2013

The Real Story Behind PGNX, OSUR, NVGN and AGEN

Marketwired January 2, 2013